Longitudinal assessment of multiplex patient-specific ctDNA biomarkers in bladder cancer for diagnosis, surveillance and recurrence
Birkenkamp-Demtröder, K., Christensen, E., Sethi, H., Sharma, S., Wu, H.-T., Taber, A., Agerbæk, M., Swenerton, R., Salari, R., Hafez, D., Nordentoft, I., Lamy, P., Srinivasan, R., Balcioglu, M., Navarro, S., Assaf, Z., Zimmermann, B., Lin, J., Bjerggaard Jensen, J., Dyrskjøt, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Are microRNAs located in genomic regions associated with cancer?
LAMY, P, ANDERSEN, Cl, DYRSKJOT, L, TORRING, N, ORNTOFT, T, WIUF, C
Published in British journal of cancer (20.11.2006)
Published in British journal of cancer (20.11.2006)
Get full text
Journal Article
Gene expression profiling of noninvasive primary urothelial tumours using microarrays
AABOE, M, MARCUSSEN, N, JENSEN, K. M.-E, THYKJAER, T, DYRSKJØT, L, ØRNTOFT, T. F
Published in British journal of cancer (14.11.2005)
Published in British journal of cancer (14.11.2005)
Get full text
Journal Article
SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation
Heebøll, S, Borre, M, Ottosen, P D, Andersen, C L, Mansilla, F, Dyrskjøt, L, Orntoft, T F, Tørring, N
Published in Histology and histopathology (01.09.2008)
Published in Histology and histopathology (01.09.2008)
Get more information
Journal Article
The miR-143/-145 cluster regulates plasminogen activator inhibitor- 1 in bladder cancer
VILLADSEN, S. B, BRAMSEN, J. B, DYRSKJOT, L, KJEMS, J, OSTENFELD, M. S, WIKLUND, E. D, FRISTRUP, N, GAO, S, HANSEN, T. B, JENSEN, Tl, BORRE, M, ORNTOFT, T. F
Published in British journal of cancer (17.01.2012)
Published in British journal of cancer (17.01.2012)
Get full text
Journal Article
MP-16.10 Expression Profiling of Laser Micro Dissected Prostate Cancer Cells Delineates Genes Associated With Biochemical Recurrence After Radical Prostatectomy
Mortensen, M, Borre, M, Benzon, D, Sørensen, K, Ørntoft, T, Dyrskjøt, L
Published in Urology (Ridgewood, N.J.) (2011)
Published in Urology (Ridgewood, N.J.) (2011)
Get full text
Journal Article
Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
Dyrskjøt, L, Zieger, K, Kissow Lildal, T, Reinert, T, Gruselle, O, Coche, T, Borre, M, Ørntoft, T F
Published in British journal of cancer (26.06.2012)
Published in British journal of cancer (26.06.2012)
Get full text
Journal Article
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors
OSTENFELD, M. S, BRAMSEN, J. B, ØRNTOFT, T. F, LAMI, P, VILLADSEN, S. B, FRISTRUP, N, SORENSEN, K. D, ULHØI, B, BORRE, M, KJEMS, J, DYRSKJØT, L
Published in Oncogene (18.02.2010)
Published in Oncogene (18.02.2010)
Get full text
Journal Article
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response
Schepeler, T, Lamy, P, Hvidberg, V, Laurberg, J R, Fristrup, N, Reinert, T, Bartkova, J, Tropia, L, Bartek, J, Halazonetis, T D, Pan, C-C, Borre, M, Dyrskjøt, L, Orntoft, T F
Published in Oncogene (01.08.2013)
Published in Oncogene (01.08.2013)
Get full text
Journal Article
Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III
Reike, M.J., Ingersoll, M.A., Müller, D.C., Zuiverloon, T.C.M., Strandgaard, T., Kamat, A.M., Williams, S.B., Seiler, R., Todenhöfer, T., Dyrskjøt, L., Nawroth, R., Goebell, P., Schmitz-Dräger, B., Sfakianos, J.P., Meeks, J., Horowitz, A., Black, P.C.
Published in Urologic oncology (01.05.2023)
Published in Urologic oncology (01.05.2023)
Get full text
Journal Article
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis
Evangelou, K, Bartkova, J, Kotsinas, A, Pateras, I S, Liontos, M, Velimezi, G, Kosar, M, Liloglou, T, Trougakos, I P, Dyrskjot, L, Andersen, C L, Papaioannou, M, Drosos, Y, Papafotiou, G, Hodny, Z, Sosa-Pineda, B, Wu, X-R, Klinakis, A, Ørntoft, T, Lukas, J, Bartek, J, Gorgoulis, V G
Published in Cell death and differentiation (01.11.2013)
Published in Cell death and differentiation (01.11.2013)
Get full text
Journal Article
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
Teo, M.T.W., Dyrskjøt, L., Nsengimana, J., Buchwald, C., Snowden, H., Morgan, J., Jensen, J.B., Knowles, M.A., Taylor, G., Barrett, J.H., Borre, M., Ørntoft, T.F., Bishop, D.T., Kiltie, A.E.
Published in Annals of oncology (01.04.2014)
Published in Annals of oncology (01.04.2014)
Get full text
Journal Article
Low ANXA10 expression is associated with disease aggressiveness in bladder cancer
Munksgaard, P P, Mansilla, F, Brems Eskildsen, A-S, Fristrup, N, Birkenkamp-Demtröder, K, Ulhøi, B P, Borre, M, Agerbæk, M, Hermann, G G, Orntoft, T F, Dyrskjøt, L
Published in British journal of cancer (25.10.2011)
Published in British journal of cancer (25.10.2011)
Get full text
Journal Article
Immunological changes following blue light cystoscopy with hexaminolevulinate in bladder cancer
Elbæk, S.K., Young-Halvorsen, K., Neijber, A., Jensen, J.B., Dyrskjøt, L.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
A0431 - Immunological changes following blue light cystoscopy with hexaminolevulinate in bladder cancer
Elbæk, S.K., Young-Halvorsen, K., Neijber, A., Jensen, J.B., Dyrskjøt, L.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
DYRSKJØT, L, REINERT, T, KNOWLES, M, HURST, C, SORGE, J, BORRE, M, ØRNTOFT, T. F, NOVORADOVSKY, A, ZUIVERLOON, Tcm, BEUKERS, W, ZWARTHOFF, E, MALATS, N, REALS, F. X, SEGERSTEN, U, MALMSTRÖM, P.-U
Published in British journal of cancer (09.10.2012)
Published in British journal of cancer (09.10.2012)
Get full text
Journal Article
Reducing the number of flexible cystoscopies in patients undergoing follow-up for non-muscle invasive bladder cancer with either flexible cystoscopy or the urinary biomarker test bladder cancer monitor: A secondary outcome from a randomised clinical trial
Karmark Dreyer, T., Brandt, S., Fabrin, K., Azawi, N., Vásquez, J.L., Ernst, A., Dyrskjøt, L., Jensen, J.B.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
A0358 - Reducing the number of flexible cystoscopies in patients undergoing follow-up for non-muscle invasive bladder cancer with either flexible cystoscopy or the urinary biomarker test bladder cancer monitor: A secondary outcome from a randomised clinical trial
Karmark Dreyer, T., Brandt, S., Fabrin, K., Azawi, N., Vásquez, J.L., Ernst, A., Dyrskjøt, L., Jensen, J.B.
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
139 Annexin A10 (ANXA10) is a marker for metastasis and disease progression in bladder cancer
Mansilla, F, Pinholt Munksgaard, P, Brems Eskildsen, A, Birkenkamp-Demtroder, K, Fristrup, N, Parm Ulhøj, B, Agerbæk, M, Ørntoft, T.F, Dyrskjøt, L
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article